Bio-Rad Laboratories, Inc.
(NYSE : BIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.36%334.841.0%$583.47m
BDXBecton, Dickinson & Co. 1.56%257.411.1%$554.08m
MDTMedtronic Plc -0.47%113.320.6%$550.69m
ISRGIntuitive Surgical, Inc. -0.84%613.082.4%$456.62m
ABTAbbott Laboratories -1.12%87.470.8%$374.48m
EWEdwards Lifesciences Corp. -1.13%231.271.2%$361.19m
DHRDanaher Corp. 0.99%161.840.7%$360.84m
BSXBoston Scientific Corp. 0.28%42.621.1%$318.95m
SYKStryker Corp. -0.09%224.271.3%$301.07m
DXCMDexCom, Inc. -3.72%291.258.2%$282.64m
ALGNAlign Technology, Inc. -4.49%260.266.4%$228.74m
BAXBaxter International, Inc. -0.39%92.701.8%$186.10m
ZBHZimmer Biomet Holdings, Inc. -0.63%157.401.7%$168.06m
TNDMTandem Diabetes Care, Inc. -2.16%88.003.9%$152.00m
ABMDABIOMED, Inc. -0.80%166.743.3%$133.16m

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the following segments: Life Sciences and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.